Cliff Asness: lighten up on growth

Anyone paying attention to history would at least have to consider “lightening up” on growth and sticking to, or even adding to, their positions in value, says Cliff Asness, co-founder of AQR Capital Management.

“I think everyone knows what they’re supposed to do here,” says Cliff Asness, the co-founder of quantitative investing group AQR. Markets generally are now so expensive that the expected return on a 60/40 portfolio (that is, the traditional mix of 60% global equities, 40% global government bonds) “is at a record low”. Meanwhile, “value” stocks are as cheap relative to “growth” stocks, such as Tesla, as they were in the 1990s tech bubble. 

Anyone paying attention to history would at least have to consider “lightening up” on growth and sticking to, or even adding to, their positions in value. Yet, while value has started to make a bit of a comeback since November, it’s only been a modest rebound and has left AQR’s overall portfolio underperforming badly in what has been a strong year for most strategies.

What comes next? It’s extremely psychologically painful to stick with a strategy – even when you know it to be time-tested and proven – when it’s struggling so badly and for such a prolonged period. But “the bottom line is that bad things sometimes happen to good, long-term processes over anything short of the very long term”, notes Asness. So he plans to continue with AQR’s tilt towards value investments. 

Indeed, “the pain of these periods might actually be the key to why some strategies actually do work over the long term”. If it wasn’t painful to stick with them, the opportunity to generate higher returns over time would be arbitraged away. Of course, “realising this doesn’t make it easy to live through”.

Recommended

Just how green is nuclear power?
Energy

Just how green is nuclear power?

Nuclear power is certainly very clean in terms of carbon emissions, but what about the radioactive waste produced as a byproduct? It’s not as much of …
22 Jan 2022
Why GSK should turn down Unilever’s billions
UK stockmarkets

Why GSK should turn down Unilever’s billions

Unilever has offered GSK £50bn for its consumer division. But while the cash will be a temptation, the deal is not in the interests of shareholders or…
22 Jan 2022
The charts that matter: the start of the big crash?
Global Economy

The charts that matter: the start of the big crash?

US tech stocks fell further this week, more than 10% down on their November high. There’s what happened to the charts that matter most to the global e…
22 Jan 2022
Cryptocurrency roundup: authorities tighten the screw
Bitcoin & crypto

Cryptocurrency roundup: authorities tighten the screw

Saloni Sardana looks at the cryptocurrency stories that caught our eye this week.
21 Jan 2022

Most Popular

Ask for a pay rise – everyone else is
Inflation

Ask for a pay rise – everyone else is

As inflation bites and the labour market remains tight, many of the nation's employees are asking for a pay rise. Merryn Somerset Webb explains why yo…
17 Jan 2022
Temple Bar’s Ian Lance and Nick Purves: the essence of value investing
Investment strategy

Temple Bar’s Ian Lance and Nick Purves: the essence of value investing

Ian Lance and Nick Purves of the Temple Bar investment trust explain the essence of “value investing” – buying something for less than its intrinsic v…
14 Jan 2022
US inflation is at its highest since 1982. Why aren’t markets panicking?
Inflation

US inflation is at its highest since 1982. Why aren’t markets panicking?

US inflation is at 7% – the last time it was this high interest rates were at 14%. But instead of panicking, markets just shrugged. John Stepek explai…
13 Jan 2022